Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir Abbas Tahami Monfared

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Neurology and Therapy|April 30, 2026
A Multimodal Latent Severity Axis for Alzheimer's Disease: Probabilistic PCA, Bayesian Trajectories, and Stage-Aware Timing EffectsBabak Haji, Amir Abbas Tahami Monfared,
Pharmacoepidemiology and Drug Safety|September 2, 2005
Accuracy and validity of using medical claims data to identify episodes of hospitalizations in patients with COPDAmir Abbas Tahami Monfared, Jacques Lelorier
The Journal of Prevention of Alzheimer'S Disease|June 8, 2025
Bridging the gap: A conversion framework for CDR-SB and MoCA scores in Alzheimer's disease and related dementiaBabak Haji, Quanwu Zhang, Amir Abbas Tahami Monfared
The Canadian Journal of Cardiology|April 2, 2004
A comparison between persistence to therapy in ALLHAT and in everyday clinical practice: a generalizability issueHéloise Cardinal, Amir Abbas Tahami Monfared, Marc Dorais, et al.
Neurology and Therapy|September 13, 2019
Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature ReviewAmir Abbas Tahami Monfared, Genevieve Meier, Richard Perry, et al.
Neurology and Therapy|January 31, 2022
Staging Disease Severity Using the Alzheimer's Disease Composite Score (ADCOMS): A Retrospective Data AnalysisAmir Abbas Tahami Monfared, Katherine Houghton, Quanwu Zhang, et al.
Pharmacoepidemiology and Drug Safety|August 10, 2005
The concept of the 'percent wasted patients' in preventive health strategiesHéloise Cardinal, Amir Abbas Tahami Monfared, Marc Dorais, et al.
Pharmacoeconomics - Open|January 9, 2019
Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in CanadaPeter L Quon, Ying Xiao, Sonja Sorensen, et al.
Neurology and Therapy|December 19, 2024
Incidence and Prevalence of Alzheimer's Disease in Medicare BeneficiariesHaixin Zhang, Amir Abbas Tahami Monfared, Quanwu Zhang, et al.
Neurology and Therapy|April 15, 2023
Understanding Barriers Along the Patient Journey in Alzheimer's Disease Using Social Media DataAmir Abbas Tahami Monfared, Yaakov Stern, Stephen Doogan, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Neurology and Therapy|April 30, 2026
A Multimodal Latent Severity Axis for Alzheimer's Disease: Probabilistic PCA, Bayesian Trajectories, and Stage-Aware Timing EffectsBabak Haji, Amir Abbas Tahami Monfared,
Pharmacoepidemiology and Drug Safety|September 2, 2005
Accuracy and validity of using medical claims data to identify episodes of hospitalizations in patients with COPDAmir Abbas Tahami Monfared, Jacques Lelorier
The Journal of Prevention of Alzheimer'S Disease|June 8, 2025
Bridging the gap: A conversion framework for CDR-SB and MoCA scores in Alzheimer's disease and related dementiaBabak Haji, Quanwu Zhang, Amir Abbas Tahami Monfared
The Canadian Journal of Cardiology|April 2, 2004
A comparison between persistence to therapy in ALLHAT and in everyday clinical practice: a generalizability issueHéloise Cardinal, Amir Abbas Tahami Monfared, Marc Dorais, et al.
Neurology and Therapy|September 13, 2019
Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature ReviewAmir Abbas Tahami Monfared, Genevieve Meier, Richard Perry, et al.
Neurology and Therapy|January 31, 2022
Staging Disease Severity Using the Alzheimer's Disease Composite Score (ADCOMS): A Retrospective Data AnalysisAmir Abbas Tahami Monfared, Katherine Houghton, Quanwu Zhang, et al.
Pharmacoepidemiology and Drug Safety|August 10, 2005
The concept of the 'percent wasted patients' in preventive health strategiesHéloise Cardinal, Amir Abbas Tahami Monfared, Marc Dorais, et al.
Pharmacoeconomics - Open|January 9, 2019
Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in CanadaPeter L Quon, Ying Xiao, Sonja Sorensen, et al.
Neurology and Therapy|December 19, 2024
Incidence and Prevalence of Alzheimer's Disease in Medicare BeneficiariesHaixin Zhang, Amir Abbas Tahami Monfared, Quanwu Zhang, et al.
Neurology and Therapy|April 15, 2023
Understanding Barriers Along the Patient Journey in Alzheimer's Disease Using Social Media DataAmir Abbas Tahami Monfared, Yaakov Stern, Stephen Doogan, et al.
Pageof 6